RF
Robbins Farley’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $146 | Hold |
3
| – | – | ﹤0.01% | 165 |
|
|
2025
Q1 | $103 | Hold |
3
| – | – | ﹤0.01% | 148 |
|
|
2024
Q4 | $119 | Hold |
3
| – | – | ﹤0.01% | 146 |
|
|
2024
Q3 | $141 | Hold |
3
| – | – | ﹤0.01% | 146 |
|
|
2024
Q2 | $163 | Hold |
3
| – | – | ﹤0.01% | 158 |
|
|
2024
Q1 | $205 | Hold |
3
| – | – | ﹤0.01% | 157 |
|
|
2023
Q4 | $188 | Hold |
3
| – | – | ﹤0.01% | 162 |
|
|
2023
Q3 | $137 | Buy |
+3
| New | +$137 | ﹤0.01% | 171 |
|
|
2023
Q2 | – | Sell |
-3
| Closed | -$136 | – | 167 |
|
|
2023
Q1 | $136 | Hold |
3
| – | – | ﹤0.01% | 181 |
|
|
2022
Q4 | $122 | Hold |
3
| – | – | ﹤0.01% | 174 |
|
|
2022
Q3 | $0 | Buy |
+3
| New | – | ﹤0.01% | 138 |
|
|
2022
Q2 | – | Sell |
-3
| Closed | – | – | 129 |
|
|
2022
Q1 | $0 | Buy |
+3
| New | – | ﹤0.01% | 140 |
|